| # | Title | Journal | Year | Citations |
|---|
| 1 | Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China | JAMA Neurology | 2020 | 5,308 |
| 2 | Amyloid-β and Tau | JAMA Neurology | 2014 | 1,416 |
| 3 | Treatment Outcomes in Patients With Newly Diagnosed Epilepsy Treated With Established and New Antiepileptic Drugs | JAMA Neurology | 2018 | 910 |
| 4 | Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019 | JAMA Neurology | 2020 | 748 |
| 5 | Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease | JAMA Neurology | 2017 | 664 |
| 6 | Inflammation and Neuroprotection in Traumatic Brain Injury | JAMA Neurology | 2015 | 625 |
| 7 | The Parkinson Pandemic—A Call to Action | JAMA Neurology | 2018 | 584 |
| 8 | Sleep Quality and Preclinical Alzheimer Disease | JAMA Neurology | 2013 | 570 |
| 9 | Seizures and Epileptiform Activity in the Early Stages of Alzheimer Disease | JAMA Neurology | 2013 | 566 |
| 10 | The Preclinical Alzheimer Cognitive Composite | JAMA Neurology | 2014 | 548 |
| 11 | Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein Antibodies | JAMA Neurology | 2014 | 519 |
| 12 | Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease | JAMA Neurology | 2019 | 512 |
| 13 | Risk of Ischemic Stroke in Patients With Coronavirus Disease 2019 (COVID-19) vs Patients With Influenza | JAMA Neurology | 2020 | 506 |
| 14 | Association of Proton Pump Inhibitors With Risk of Dementia | JAMA Neurology | 2016 | 459 |
| 15 | New Clinical Subtypes of Parkinson Disease and Their Longitudinal Progression | JAMA Neurology | 2015 | 456 |
| 16 | Current Concepts in Diagnosis and Treatment of Functional Neurological Disorders | JAMA Neurology | 2018 | 455 |
| 17 | Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology | JAMA Neurology | 2019 | 455 |
| 18 | Apolipoprotein E Genotype and Sex Risk Factors for Alzheimer Disease | JAMA Neurology | 2017 | 454 |
| 19 | Worldwide Incidence of Aneurysmal Subarachnoid Hemorrhage According to Region, Time Period, Blood Pressure, and Smoking Prevalence in the Population | JAMA Neurology | 2019 | 452 |
| 20 | Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease | JAMA Neurology | 2019 | 436 |
| 21 | History, Applications, and Mechanisms of Deep Brain Stimulation | JAMA Neurology | 2013 | 420 |
| 22 | Self-reported Sleep and β-Amyloid Deposition in Community-Dwelling Older Adults | JAMA Neurology | 2013 | 414 |
| 23 | Evaluation of Galcanezumab for the Prevention of Episodic Migraine | JAMA Neurology | 2018 | 413 |
| 24 | Associations Between Midlife Vascular Risk Factors and 25-Year Incident Dementia in the Atherosclerosis Risk in Communities (ARIC) Cohort | JAMA Neurology | 2017 | 404 |
| 25 | Vitamin D as an Early Predictor of Multiple Sclerosis Activity and Progression | JAMA Neurology | 2014 | 402 |
| 26 | Parkinson Disease Subtypes | JAMA Neurology | 2014 | 397 |
| 27 | Clinical Significance of Magnetic Resonance Imaging Markers of Vascular Brain Injury | JAMA Neurology | 2019 | 390 |
| 28 | Aberrations in Peripheral Inflammatory Cytokine Levels in Parkinson Disease | JAMA Neurology | 2016 | 385 |
| 29 | Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy | JAMA Neurology | 2016 | 383 |
| 30 | A Multicenter Study of Glucocerebrosidase Mutations in Dementia With Lewy Bodies | JAMA Neurology | 2013 | 374 |
| 31 | Association of Perivascular Localization of Aquaporin-4 With Cognition and Alzheimer Disease in Aging Brains | JAMA Neurology | 2017 | 367 |
| 32 | Midlife Hypertension and 20-Year Cognitive Change | JAMA Neurology | 2014 | 358 |
| 33 | Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis | JAMA Neurology | 2020 | 357 |
| 34 | Frequency and Characteristics of Isolated Psychiatric Episodes in Anti–N-Methyl-d-Aspartate Receptor Encephalitis | JAMA Neurology | 2013 | 354 |
| 35 | Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression | JAMA Neurology | 2016 | 354 |
| 36 | Dementia Risk After Traumatic Brain Injury vs Nonbrain Trauma | JAMA Neurology | 2014 | 352 |
| 37 | Time Course and Diagnostic Accuracy of Glial and Neuronal Blood Biomarkers GFAP and UCH-L1 in a Large Cohort of Trauma Patients With and Without Mild Traumatic Brain Injury | JAMA Neurology | 2016 | 348 |
| 38 | Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies | JAMA Neurology | 2020 | 342 |
| 39 | Association of Traumatic Brain Injury With Late-Life Neurodegenerative Conditions and Neuropathologic Findings | JAMA Neurology | 2016 | 337 |
| 40 | The Idiopathic Intracranial Hypertension Treatment Trial | JAMA Neurology | 2014 | 336 |
| 41 | Blood Biomarkers for Brain Injury in Concussed Professional Ice Hockey Players | JAMA Neurology | 2014 | 336 |
| 42 | Congenital Zika Virus Infection | JAMA Neurology | 2016 | 334 |
| 43 | Sleep and Circadian Rhythm Regulation in Early Parkinson Disease | JAMA Neurology | 2014 | 333 |
| 44 | Evaluation of No Evidence of Disease Activity in a 7-Year Longitudinal Multiple Sclerosis Cohort | JAMA Neurology | 2015 | 328 |
| 45 | Effect of 1 Night of Total Sleep Deprivation on Cerebrospinal Fluid β-Amyloid 42 in Healthy Middle-Aged Men | JAMA Neurology | 2014 | 320 |
| 46 | Association of Cerebrospinal Fluid β-Amyloid 1-42, T-tau, P-tau181, and α-Synuclein Levels With Clinical Features of Drug-Naive Patients With Early Parkinson Disease | JAMA Neurology | 2013 | 318 |
| 47 | Magnetic Resonance Imaging Alteration of the Brain in a Patient With Coronavirus Disease 2019 (COVID-19) and Anosmia | JAMA Neurology | 2020 | 315 |
| 48 | Neurologic and Radiographic Findings Associated With COVID-19 Infection in Children | JAMA Neurology | 2020 | 314 |
| 49 | A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease | JAMA Neurology | 2014 | 312 |
| 50 | Development of a Biochemical Diagnosis of Parkinson Disease by Detection of α-Synuclein Misfolded Aggregates in Cerebrospinal Fluid | JAMA Neurology | 2017 | 312 |
